Unravelling disparate roles of NOTCH in bladder cancer

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• The Notch pathway's role in cancer is context-dependent, with limited understanding in bladder cancer.
• NOTCH1 is frequently downregulated in bladder cancer, suggesting a tumor-suppressive function.
• NOTCH2 appears to promote bladder cancer progression through various mechanisms.

Purpose of the Study:

• To elucidate the distinct roles of NOTCH1 and NOTCH2 in bladder cancer.
• To investigate the implications of Notch pathway dysregulation in bladder tumorigenesis.
• To explore potential therapeutic strategies targeting the Notch pathway in bladder cancer.

Main Methods:

• Analysis of NOTCH1 copy number and expression in bladder cancer tissues.
• Functional studies using bladder cancer cell lines to assess NOTCH1 activation.
• Utilizing transgenic models with bladder-specific inactivation of gamma-secretase components.
• Investigating NOTCH2's impact on cell proliferation, metastasis, and stemness.

Main Results:

• NOTCH1 copy number and expression are reduced in bladder cancer.
• NOTCH1 activation inhibits proliferation in bladder cancer cell lines.
• NOTCH2 promotes proliferation and metastasis via epithelial-to-mesenchymal transition, cell cycle progression, and stemness maintenance.
• Bladder-specific inactivation of gamma-secretase components promotes bladder cancer in transgenic models.

Conclusions:

• NOTCH1 functions as a tumor suppressor in bladder cancer.
• NOTCH2 acts as an oncogene, promoting bladder cancer progression.
• The opposing roles of NOTCH1 and NOTCH2 offer potential therapeutic avenues for bladder cancer by modulating the Notch pathway.